<DOC>
<DOCNO>
EP-0012083
</DOCNO>
<TEXT>
<DATE>
19800611
</DATE>
<IPC-CLASSIFICATIONS>
A61P-37/00 C07J-41/00 A61P-37/04 C07J-31/00 A61K-39/39 
</IPC-CLASSIFICATIONS>
<TITLE>
immunologic adjuvant, process for preparation and vaccine containing such adjuvant.
</TITLE>
<APPLICANT>
merck & co incus<sep>merck & co., inc.<sep>merck &amp; co., inc.126, east lincoln avenue p.o. box 2000rahway new jersey 07065-0900us <sep>
</APPLICANT>
<INVENTOR>
bugianesi robert lus  <sep>ponpipom mitree mus<sep>shen tsung-yingus<sep>bugianesi, robert l.<sep>ponpipom, mitree m.<sep>shen, tsung-ying<sep>bugianesi, robert l.195 colonia blvd.colonia, new jersey 07067us<sep>ponpipom, mitree m.431 brookview courtbranchburg, new jersey 08876us<sep>shen, tsung-ying935 minisink waywestfield, new jersey 07090us<sep>
</INVENTOR>
<ABSTRACT>
glycolipid compounds of the formulae    r is    are useful immunologic adjuvants in vaccines.  
</ABSTRACT>
</TEXT>
</DOC>
